Summary. Male rats were treated with 5 or 20 mg cyproterone acetate/kg/day or 20 mg cyproterone/rat/day for 1, 2, 3, 4 or 5 weeks. There was some reduction in fertility with both compounds, the maximum effect occurring after 5 
Introduction
defined an antiandrogen "as a substance which prevents androgens from expressing their activity at target sites". The precise mechanism whereby antiandrogens such as cyproterone and cyproterone acetate inhibit androgen activity both peripherally and centrally and the overall effects produced in vivo by the drugs have evoked numerous studies (Stern & Eisenfeld, 1969; Singh & Rajalakshmi, 1970; Steinbeck, Mehring & Neumann, 1971; Walsh, Swerdloff & Odell, 1972; Hasan, Neumann & Schenck, 1973; Neumann & Steinbeck, 1975;  Schenck, Elger, Schopflin & Neumann, 1975) .
Because of the powerful progestagenic properties conferred on cyproterone acetate by the presence of the acetate group, its influence on the hypothalamus-pituitary-gonad system differs from that of cyproterone (Neumann & Steinbeck, 1975) . Although interference with this complex system can cause difficulties of interpretation, it seemed justifiable to examine the effects of these two anti¬ androgens on the function of the testis, particularly with regard to fertility, testosterone concentra¬ tions and the composition of the epididymal plasma.
Materials and Methods
Mature male (300-400 g) and female (200-250 g) (Rowe et al., 1974) .
Assay blanks ranged from 10 to 60 pg (mean 43 pg). The mean % recovery of [3H]testosterone from rat plasma (100 pi) was 92-2±0-8 (S.E.M., n= 10). The intra-assay precision assessed by measuring the same sample ten times within a single assay (mean 340 ng/100 ml) was 5%. The cross-reaction with cyproterone and cyproterone acetate was less than 0-01 %.
Experiment II
Male rats were separated into 20 groups of 4 or 5 rats (total = 97) and treated as shown in Table 2 . On the day following the final injection, the animals were anaesthetized with urethane (14% w/v in water; 10-0 ml/kg i.p.) and the contents of each cauda epididymidis were collected as described by Back, Shenton & Glover (1974) . The fluid from the right and left epididymis of each animal was combined. After centrifugation at 12,000 g-for 60 min the spermatocrit was recorded and the epididy¬ mal plasma removed and stored at -20°C. When all the samples had been collected they were individually analysed for sodium ions (Na+), potassium ions (K+), glycerylphosphorylcholine (GPC), acid phosphatase and lactate dehydrogenase (LDH) as described by Back et al. (1974) .
Results

Experiment I
The effects of cyproterone acetate and cyproterone on fertility were variable (Table 1 ). All the males mated and fertility was not completely inhibited by any treatment.
Epididymal weights were significantly reduced after 2 weeks of treatment with 20 mg cyproterone acetate/kg and at 5 weeks the regression was such (Text-fig. la) that it was possible to obtain only small volumes of fluid from the lumen. A significant reduction in weight was observed only at 5 weeks in the rats treated with 5 mg cyproterone acetate/kg. These falls in epididymal weight were associated with significant declines in the diameter of the epididymal lumen ( A significant increase in testicular weight occurred in response to the low dose of cyproterone acetate after 3 weeks (Text- fig. Id) but the most notable change was the decline in weight in the highdose animals at 5 weeks, which was correlated with a decrease in the diameter of the seminiferous tubules (Table 1) . Treatment with cyproterone had no effect on testicular weight.
Peripheral plasma testosterone concentrations increased significantly only after treatment with 20 mg cyproterone acetate/kg for 1 week and with cyproterone for 2 weeks (Text- fig. lc ).
Experiment II
The changes in the composition of epididymal plasma were relatively small and rather variable ( Table 2 ). The most marked changes were an increase in the level of Na+ after cyproterone treatment for 1 and 2 weeks, and a decrease in acid phosphatase after cyproterone acetate treatment (both doses) for 3 weeks. With the high dose of cyproterone acetate the fall in acid phosphatase was followed by a considerable increase.
Discussion
In the present study the testosterone data have been expressed logarithmically because previous work in the rat (Bartke, Steele, Musto & Caldwell, 1973) has shown that testosterone values normally fluctuate between low and high levels with an exponential decline from peak levels. Although we took only one blood sample, the range of testosterone concentrations in the control animals was 160-1900 ng/100 ml, a value in agreement with those of Bartke et al. (1973) .
Although cyproterone and cyproterone acetate are both antiandrogens, cyproterone is a 'pure' antiandrogen while cyproterone acetate also has antigonadotrophic activity (Neumann & Steinbeck, 1975) . This could be the reason why the plasma testosterone levels did not change significantly in the present study after treatment with the lower dose of cyproterone acetate. The antiandrogenic effects were revealed peripherally, however, by the regression of the seminal vesicles and epididymis after 2 and 5 weeks respectively. Treatment with the high dose of cyproterone acetate (20 mg/kg) resulted in an initial increase in plasma testosterone, suggesting that the antiandrogenic activity was initially greater than the progestational activity at the receptor site^o f the hypothalamus-hypophysis. The subsequent reduction to control values could be explained by the balancing out of the observed increase in androgen secretion and the progestational activity with the antiandrogenic effects of the compound. Neumann & Steinbeck (1975) found that treatment with 10 mg cyproterone/day at first enhances serum testosterone levels even though the effect is only transitory. The present work confirms this finding, plasma testosterone levels being elevated at 2 weeks and thereafter returning to control levels. Thus, the initial increase in the secretion of testicular androgen appears to overcome the antiandro¬ genic effect of cyproterone at the hypothalamic-hypophysial receptor sites.
The occurrence of a reduction in seminal vesicle weight before that in epididymal weight after treatment with cyproterone acetate suggests that the seminal vesicles are more sensitive to androgen deprivation than the epididymis, a finding contrary to that of other workers (Prasad et al., 1970; Prasad, Rajalakshmi & Reddy, 1972 ; Rajalakshmi & Prasad, 1975) .
In contrast to the rapid and prolonged effect of cyproterone acetate, the administration of cypro¬ terone resulted in a decrease in seminal vesicle weight only after 1 and 2 weeks of treatment. The return of plasma testosterone values to normal after 3 weeks of treatment indicates that the antiandro¬ genic properties of cyproterone are less potent than those of cyproterone acetate. The reductions in testicular weight and seminiferous tubule diameter after treatment with the high dose of cyproterone acetate (20 mg/kg) for 5 weeks are also indicative of the greater antiandrogenic properties of this steroid.
The composition of epididymal plasma is due to the activities of the spermatozoa and the epididy¬ mal cells. Previous work in the rabbit (Jones & Glover, 1973) has shown that withdrawal of androgen by castration causes considerable changes in the absorptive and secretory activity of the epithelial epididymal cells. In contrast, Back, Glover, Shenton & Boyd (1975) suggested that the antifertility action of a-chlorohydrin in rats was due to a direct effect on the spermatozoa which released lactate dehydrogenase and glutamic oxaloacetic transaminase. An adverse effect on the epididymal milieu was expected with cyproterone and cyproterone acetate because the latter has been reported to decrease preferentially epididymal secretion (Prasad et al., 1970; Prasad et al., 1972; Rajalakshmi & Prasad, 1975) . In the present study, the secretory activity of the epididymis was assessed by measuring the concentration of GPC in epididymal plasma because it is known to be a specific secretory product of epididymal cells (Dawson, 
